DLX1 and nonpapillary renal cell carcinoma: Although the correlation between DLX1 and miR-4922 has never been documented before, the involvements of target mRNAs have been well-established in the antioncogenic role of miR-4922, such as CDK6 downregulation in the above-mentioned ccRCC inhibition [16].